By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today reported that its first-quarter revenues increased 25 percent as sales of its imaging and LabChip products returned strong double-digit gains.

The Hopkinton, Mass.-based firm brought in total revenues of $35.8 million for the three-month period ended March 31, compared to $28.7 million for the first quarter of 2010. Its revenues were driven by sales of its imaging and LabChip products, while its automation business declined.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.